Search Results 261-270 of 24172 for Ovary
Investigators in the Mayo Clinic Ovarian Cancer SPORE are exploring natural killer (NK) cells as an adoptive cellular therapy for ovarian cancer.
— A new test developed by researchers at Mayo Clinic shows which mutations in the BRCA2 gene make women susceptible to developing breast or ovarian cancers.
Diabetic patients with ovarian cancer who took the drug metformin for their diabetes had a better survival rate than patients who did not take it, a study ...
Intro: “You have ovarian cancer.” Those are words that are tough to hear. But according to the Centers for Disease Control and Prevention, more than 20- ...
The purpose of this study is to determine whether a common virus, cytomegalovirus (CMV), may increase fatigue and other symptoms following treatment for ovarian ...
One sequence associated with ovarian cancer is the first known BRCA1-specific risk sequence for the disease. The researchers were then able to use their results ...
This is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study of niraparib as maintenance in platinum sensitive ovarian cancer patients ...
The study population is adult patients with asymptomatic recurrent ovarian cancer who have an elevation in their CA-125 level. Participation eligibility.
MINNEAPOLIS — Ovarian and brain cancer, tuberculosis, imaging for Alzheimer's disease and new approaches to treating glaucoma are the serious medical ...
Depo-Provera most often stops the ovaries from releasing an egg. So there's no ovulation. Depo-Provera also thickens mucus in the lower end of the uterus ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.